TheraCryf (FRA:8EV) Price-to-Operating-Cash-Flow : (As of May. 21, 2024)

View and export this data going back to 2018. Start your Free Trial

What is TheraCryf Price-to-Operating-Cash-Flow?

As of today (2024-05-21), TheraCryf's share price is €0.0005. TheraCryf's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.01. Hence, TheraCryf's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for TheraCryf's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:8EV's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.93
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

TheraCryf's Cash Flow from Operations per share for the six months ended in Sep. 2023 was €-0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 9.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 16.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -0.80% per year.

During the past 11 years, TheraCryf's highest 3-Year average Operating Cash Flow per Share Growth Rate was 27.90% per year. The lowest was -57.50% per year. And the median was 8.65% per year.

TheraCryf Price-to-Operating-Cash-Flow Historical Data

The historical data trend for TheraCryf's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TheraCryf Price-to-Operating-Cash-Flow Chart

TheraCryf Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

TheraCryf Semi-Annual Data
	Mar13	Mar14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of TheraCryf's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, TheraCryf's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TheraCryf's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TheraCryf's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where TheraCryf's Price-to-Operating-Cash-Flow falls into.

TheraCryf Price-to-Operating-Cash-Flow Calculation

TheraCryf's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.0005	/	-0.014
	=

TheraCryf's Share Price of today is €0.0005.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. TheraCryf's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

TheraCryf Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of TheraCryf's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

TheraCryf (FRA:8EV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (FRA:8EV) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

EVG:UK

Address

Congleton Road, Suite 24G13- Block 24, Alderley Park, Nether Alderley, GBR, SK10 4TG

Website

https://www.evgen.com

Evgen Pharma PLC is a UK-based clinical-stage drug development company. The company is focused on the development of sulforaphane-based compounds. Its core technology is Sulforadex, which synthesis and stabilizes the naturally occurring compound sulforaphane. Geographically, the company operates only in the United Kingdom. It is engaged in the treatment of breast cancer and Subarachnoid Haemorrhage.

TheraCryf (FRA:8EV) Headlines

No Headlines